132 results
8-K
EX-99.1
ATXI
Avenue Therapeutics Inc
1 May 24
Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross Proceeds
4:28pm
, they will remain subject to substantial regulatory scrutiny; the effects of current and future laws and regulations relating to fraud and abuse, false
8-K
EX-99.1
ATXI
Avenue Therapeutics Inc
26 Apr 24
Avenue Therapeutics Announces Reverse Stock Split
4:39pm
approval, they will remain subject to substantial regulatory scrutiny; the effects of current and future laws and regulations relating to fraud
8-K
EX-99.1
0ap2l1t xl0ty5
18 Mar 24
Avenue Therapeutics Reports Full Year 2023 Financial Results and Recent Corporate Highlights
4:10pm
424B3
x0yya1l0c402 e9a0
2 Feb 24
Prospectus supplement
12:00am
8-K
EX-10.2
2g4zam
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
424B4
sulqbagdlji5y l6b0my
2 Nov 23
Prospectus supplement with pricing info
9:00am
FWP
j4v4j7ep
5 Oct 23
Free writing prospectus
5:05pm
FWP
j2ybww s4
3 Oct 23
Free writing prospectus
5:47pm